30.10.2023 - Update includes supplemental information and provides additional time to complete regulatory review Biora anticipates remaining on track with its phase 1 clinical trial execution timeline SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) - Biora ... Seite 1